Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

PUBLIC MEETING ON DEVICE GENERAL/SPECIFIC INTENDED USES GUIDANCE UNDER CONSIDERATION BY FDA; HIMA FORMING TASK FORCE TO PROVIDE INPUT ON POLICY

This article was originally published in The Gray Sheet

Executive Summary

FDA may seek input on the types of specific intended uses covered by a general device claim through a public meeting, Joseph Sheehan, regulations staff director in FDA's Center for Devices and Radiological Health, said Feb. 4 at a Health Industry Manufacturers Association meeting in Washington, D.C. CDRH plans to publish a guidance on the subject before the Aug. 18 deadline stipulated in the FDA Modernization Act.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT009561

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel